Paxlovid (COVID-19 antiviral) access criteria assessment tool
This guide is intended to help assess whether someone is eligible for funded Paxlovid.
Notes:
BPACNZ | Access criteria for COVID-19 antivirals: Determine priority by need(external link)
# supplemental oxygen to maintain oxygen saturation >93%, or at or above baseline, due to COVID-19 infection (excluding people with chronic resting hypoxia as a result of conditions other than COVID-19)
* Identifying people who are severely immunocompromised
** Health conditions that include severe or very advanced disease including, but not limited to, severe neurological, cardiovascular, renal and respiratory conditions.
*** High risk factors for severe illness from COVID-19
You may get an error message saying you have unsaved changes when you leave or refresh this page. You can ignore this message.
If you don't get a result, refresh and start again. Changing answers to earlier questions may cause this.
Updated 1 September 2025.